clinivation

  • Sign In
  • Contact
  • About
    • What We Do
    • Newsroom
    • Our Partners
    • Events
    • Careers
    • Contact
  • Solutions
    • Business Development
    • Clinical Operations
    • Commercial Operations
    • Health Policy & Reimbursement
    • Medical Affairs
    • Portfolio Management
    • Regulatory Affairs
    • Research & Development
  • Products
    • CareSite
    • ClinicalSuite
    • Cloud
    • Conformity
    • ForeSight
    • Global
    • Prospectus
    • RealWorld
    • RegistrySuite
    • ValueLogic
    • WorldView
  • Services & Support
    • Customer Support
    • Solution Services
    • CRO Services
    • Professional Services
    • Innovation Workshops
  • Resources
    • Data Sheets
  • Customers
    • Customer Success
Home / News / Advanced Neuromodulation Systems Selects Clinivation Global Enterprise Solution for Market Clearance Management
clinivation
CONTACT US

Advanced Neuromodulation Systems Selects Clinivation Global Enterprise Solution for Market Clearance Management

Emerging leader in chronic pain and neurological medical devices selects Global 2.0 to manage its medical device approvals and submissions worldwide.

Framingham, MA, June 9, 2005 – clinivation, Inc. announced today that ANS, Advanced Neuromodulation Systems, Inc. (NASDAQ NM: ANSI) has selected clinivation Global™ 2.0 software.

“ANS-medical is clearly an emerging leader in the development of solutions for chronic pain and other neurological conditions, and we are delighted they have selected clinivation Global 2.0 to help them build and track their medical device approvals and submissions worldwide,” said Joseph Kozikowski, M.D., clinivation’s Founder, Chairman, and Chief Executive Officer.

Clinivation Global 2.0 software enables medical device companies to sell more products to more countries faster and easier than ever before. Global 2.0 is the first complete solution targeted at automating the business processes for medical device approvals worldwide.

About Advanced Neuromodulation Systems, Inc.

Advanced Neuromodulation Systems designs, develops, manufactures and markets implantable systems used to manage chronic intractable pain and other disorders of the central nervous system. Fortune magazine recently ranked ANS as the 8th fastest growing small company in its annual list of the Top 200 Fastest Growing Small Companies in the United States. Forbes magazine recently recognized ANS as one of America’s 200 Best Small Companies. Frost & Sullivan, an international strategic market research firm, also recently presented ANS with its Product Innovation Award, recognizing ANS as the technology innovation leader in the neurostimulation market and ANS’ Genesis® Implantable Pulse Generator system as the most advanced fully implantable spinal cord stimulator on the market.

For more information about ANS, visit the company website at www.ans-medical.com

Share

About clinivation

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

Media Contact

Corporate Communications
irpr@clinivation.com

clinivation, Inc.
Suite 1800
245 First Street
Cambridge, MA 02142
U.S.A.
Phone +1 617‐444‐8500

About

  • What We Do
  • Newsroom
  • Our Partners
  • Events
  • Careers
  • Contact

Solutions

  • Business Development
  • Clinical Operations
  • Commercial Operations
  • Health Policy & Reimbursement
  • Medical Affairs
  • Portfolio Management
  • Regulatory Affairs
  • Research & Development

Products

  • CareSite
  • ClinicalSuite
  • Cloud
  • Conformity
  • ForeSight
  • Global
  • Prospectus
  • RealWorld
  • RegistrySuite
  • ValueLogic
  • WorldView

Services & Support

  • Customer Support
  • Solution Services
  • CRO Services
  • Professional Services
  • Innovation Workshops

Resources

  • Data Sheets

Customers

  • Customer Success
American Flag US: +1 (617) 444‐8500
Contact Us
  • Privacy
  • Terms Of Use
  • Trademarks
  • Site Map

© 2023 · clinivation, INC.

Clinivation solutions deliver the digital advantage to outperform in new business environments with innovative and better ways to succeed in global development and commercialization.

Our cross‐functional software brings people and knowledge to the point of action to eliminate revenue traps, overcome process complexity, and enable execution with full visibility, decision support, and controls.

Trusted for millions of products by hundreds of companies worldwide, our modular, interoperating applications yield new, scalable operating models that directly
connect biomedical innovation with high‐value inflection points and business growth.

The world’s leading medtech, pharmaceutical, and biotech organizations partner with clinivation because of our industry expertise and our transformative solutions
that seamlessly integrate existing business processes and enterprise infrastructure‐ leveraging cloud, hybrid, and on‐premises architectures.

Our vision is to inspire our shared purpose of bringing innovation to life with the value of information technology.

​